Conditions: Sexual Dysfunctions, Psychological
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 748
Healthy volunteers: no

Brief summary:
The objective of this trial is to assess the safety and efficacy of 24-week course of flibanserin for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in naturally postmenopausal women.

Detailed description:

Arms:
arm 1: Flibanserin 100 mg administered at bedtime arm 2: This is the matched placebo which will be administered two tablets daily at bedtime.

Interventions: intervention 1: Flibanserin intervention 2: Placebo
Intervention descriptions: intervention 1: Flibanserin 100mg administered at bedtime for 24 weeks intervention 2: This is the matched placebo which will be administered two tablets daily at bedtime.

Protocol document: